Chlorhexidine Impregnated Cloths to Prevent Skin and Soft Tissue Infections in Marine Officer Candidates

Sponsor
Uniformed Services University of the Health Sciences (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT00475930
Collaborator
(none)
1,563
1
2
6
258.6

Study Details

Study Description

Brief Summary

Outbreaks of skin and soft tissue infections (SSTI) related to community associated Methicillin-resistant Staphylococcus aureus (MRSA) have become increasingly common in military training units. Risk factors for MRSA related SSTI such as crowding, poor hygiene and shared equipment are often hard to avoid in a military training environment, often designed to simulate battlefield conditions.

It has recently been demonstrated that military recruits colonized with MRSA may be at increased risk of developing SSTI. Studies in the hospital environment have shown that decolonizing inpatients known to carry MRSA decreases the rates of MRSA related infections in the treated individuals and also in their inpatient unit as a whole.

The investigators propose a randomized, double blind, placebo controlled trial to:
  1. Evaluate the effectiveness, feasibility, and safety of chlorhexidine body cloths, self-administered three times weekly, in preventing SSTI among recruits in military training facilities; and

  2. Evaluate the effectiveness of chlorhexidine body cloths in decreasing rates of Staphylococcus aureus colonization among military recruits.

Condition or Disease Intervention/Treatment Phase
  • Drug: 2% chlorhexidine gluconate (CHG) impregnated cloths
  • Drug: Comfort Bath cloths (placebo cloths)
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
1563 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Prevention
Official Title:
Chlorhexidine Impregnated Cloths to Prevent Skin and Soft Tissue Infections in Marine Officer Candidates: A Randomized, Double-Blind, Placebo-Controlled Trial
Study Start Date :
May 1, 2007
Actual Primary Completion Date :
Nov 1, 2007
Actual Study Completion Date :
Nov 1, 2007

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

2% chlorhexidine gluconate impregnated cloths, self applied three times weekly

Drug: 2% chlorhexidine gluconate (CHG) impregnated cloths
self applied three times per week
Other Names:
  • Sage Products Inc.
  • Placebo Comparator: 2

    Comfort Bath cloths, self applied three times weekly

    Drug: Comfort Bath cloths (placebo cloths)
    self applied three times weekly
    Other Names:
  • Sage Products Inc.
  • Outcome Measures

    Primary Outcome Measures

    1. The rate of skin and soft tissue infections among platoons enrolled in OCS. [May - Nov 2007]

    Secondary Outcome Measures

    1. The rate of new S. aureus colonization of the nares and axilla among platoons enrolled in OCS. [May- Nov 2007]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 35 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Enrolled in US Marine Officer Candidates School

    • Age 18-35 years

    • Provide documented informed consent and HIPAA authorization

    Exclusion Criteria:
    • Is currently taking oral antibiotics and will continue to take antibiotics during the study (such as antibiotics used to treat acne)

    • Has a known or suspected allergy or intolerance to chlorhexidine (Hibistat, Hibiclens)

    • Is currently using certain skin products and is uninterested in stopping use of the products during the study

    • Pregnant or breastfeeding

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Officer Candidates School - Marine Corps Base Quantico Quantico Virginia United States 22134

    Sponsors and Collaborators

    • Uniformed Services University of the Health Sciences

    Investigators

    • Principal Investigator: Timothy J Whitman, DO, National Naval Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00475930
    Other Study ID Numbers:
    • HU87F7
    First Posted:
    May 21, 2007
    Last Update Posted:
    Sep 2, 2009
    Last Verified:
    Sep 1, 2009

    Study Results

    No Results Posted as of Sep 2, 2009